Wall Street Zen Upgrades NextPlat (NASDAQ:NXPL) to Hold

NextPlat (NASDAQ:NXPL) was upgraded by equities researchers at Wall Street Zen to a “hold” rating in a report released on Saturday.

Several other equities research analysts have also issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of NextPlat in a report on Friday, August 7th. Litchfield Hills Research started coverage on shares of NextPlat in a report on Wednesday, June 24th. They set a “buy” rating and a $11.00 price target on the stock. Finally, Zacks Research upgraded shares of NextPlat to a “hold” rating in a research report on Thursday, June 25th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $11.00.

NextPlat Stock Performance

NASDAQ:NXPL opened at $9.15 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.92 and a current ratio of 2.29. The stock has a 50-day simple moving average of $6.65 and a two-hundred day simple moving average of $6.02. The firm has a market capitalization of $24.80 million, a PE ratio of -2.49 and a beta of 1.83. NextPlat has a 52-week low of $3.38 and a 52-week high of $11.10.

NextPlat (NASDAQ:NXPL) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.16. NextPlat had a negative return on equity of 54.66% and a negative net margin of 20.38%.The firm had revenue of $11.88 million for the quarter, compared to the consensus estimate of $11.00 million. Analysts forecast that NextPlat will post -0.85 EPS for the current year.

Hedge Funds Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC bought a new position in shares of NextPlat Corp. (NASDAQ:NXPL) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by institutional investors.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.